Document Detail


HIF-mediated endothelial response during cancer progression.
MedLine Citation:
PMID:  22562456     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tumour growth at primary or secondary extravasation sites leads to localised regions of reduced oxygen tension (hypoxia) in cells both within and surrounding the tumour. Although the angiogenic response of the tumour cell to hypoxia has been widely examined, the effect of hypoxia on other cell types within the tumour microenvironment is less clear. The endothelium is highly responsive to local hypoxia and regulates tumour cell dissemination and ultimately metastatic success through differential regulation of hypoxia-inducible transcription factors (HIFs). The endothelial response to hypoxia particularly mediates key processes that regulate tumour vascularisation and cancer progression, including proliferation, migration, adherence, and vascular permeability. This article describes current understanding of the HIF-mediated endothelial response to hypoxia during cancer progression. Endothelial HIF signalling regulates tumour growth and metastasis and is therefore an attractive putative target for treatments that inhibit cancer progression.
Authors:
Colin E Evans; Cristina Branco-Price; Randall S Johnson
Related Documents :
22771646 - Amygdalin inhibits angiogenesis in the cultured endothelial cells of diabetic rats.
22659166 - Force-dependent bond dissociation govern rolling of hl-60 cells through e-selectin.
22306966 - Simvastatin disrupts cytoskeleton and decreases cardiac fibroblast adhesion, migration ...
22842186 - In vitro anti-metastatic activity of enterolactone, a mammalian lignan derived from fla...
23872466 - Molecular methods to investigate adhesion, transmigration, invasion and intracellular s...
3355616 - Effect of hypertension on lysosomal enzyme activities in aortic endothelial cells.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2012-05-08
Journal Detail:
Title:  International journal of hematology     Volume:  95     ISSN:  1865-3774     ISO Abbreviation:  Int. J. Hematol.     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-05-16     Completed Date:  2012-09-07     Revised Date:  2014-02-24    
Medline Journal Info:
Nlm Unique ID:  9111627     Medline TA:  Int J Hematol     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  471-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anoxia / metabolism*,  pathology
Endothelial Cells / metabolism,  pathology*
Humans
Hypoxia-Inducible Factor 1 / metabolism*
Neoplasm Metastasis / pathology
Neoplasms / blood supply,  metabolism*,  pathology*
Oxygen / metabolism
Signal Transduction
Grant Support
ID/Acronym/Agency:
092738//Wellcome Trust; //Wellcome Trust
Chemical
Reg. No./Substance:
0/Hypoxia-Inducible Factor 1; S88TT14065/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Two-photon laser polymerization: from fundamentals to biomedical application in tissue engineering a...
Next Document:  Detection of atrial fibrillation after cryptogenic stroke.